TrialBMJ (Clinical research ed.)2022

Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.

Walter Ageno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.